RankingsPricing
  1. US-listed companies
  2. AMGEN INC
  3. Financials
  4. EBITDA

AMGEN INCAMGN

Market cap
$175.3B
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Dec 31, 202412,850+7.37%
Dec 31, 202311,968-7.82%
Dec 31, 202212,983+17.63%
Dec 31, 202111,037-13.37%
Dec 31, 202012,740+7.24%
Dec 31, 201911,880-2.69%
Dec 31, 201812,209+2.36%
Dec 31, 201711,928+0.24%
Dec 31, 201611,899+12.49%
Dec 31, 201510,578+27.71%
Dec 31, 20148,283+15.80%
Dec 31, 20137,153+7.32%
Dec 31, 20126,665+24.07%
Dec 31, 20115,372-18.13%
Dec 31, 20106,562

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)